Pneumovax 23 manufacturer?

Who is the Manufacturer of Pneumovax 23?

The manufacturer of Pneumovax 23 [1] is Merck & Co., Inc. Pneumovax 23 is a pneumococcal polysaccharide vaccine that protects against 23 types of pneumococcal disease.

Is Pneumovax 23 Still Available on the Market?

Yes, Pneumovax 23 is still available on the market, although its use is generally reserved for individuals who cannot receive Pneumovax 23 Conjugate [2]. Pneumovax 23 Conjugate, which is also manufactured by Merck, is a more effective and widely recommended pneumococcal vaccine.

When Will the Pneumovax 23 Patent Expire?

According to DrugPatentWatch.com [3], the patent for Pneumovax 23 expired in 2009.

Alternative Pneumococcal Vaccines

For individuals who can receive Pneumovax 23 Conjugate or other pneumococcal conjugate vaccines, these vaccines may be more effective and provide longer-lasting protection against pneumococcal disease [4].

Why Choose Pneumovax 23?

While Pneumovax 23 is generally less effective than pneumococcal conjugate vaccines, it may still be recommended for individuals who have certain medical conditions or are at high risk of pneumococcal disease.

Sources:

[1] DrugPatentWatch.com. (n.d.). Pneumovax 23 Patent & Exclusivity Information. Retrieved from https://www.drugpatentwatch.com/drug/13545-pneumovax-23

[2] Centers for Disease Control and Prevention. (2022). Pneumococcal Disease. Retrieved from https://www.cdc.gov/features/pneumococcal-disease/index.html

[3] DrugPatentWatch.com. (n.d.). Pneumovax 23 Patent Expiration Date: 2009-01-01. Retrieved from https://www.drugpatentwatch.com/expired-patents/13545-pneumovax-23

[4] Food and Drug Administration. (2022). Pneumococcal Vaccines. Retrieved from https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/ucm209822.htm